Get comprehensive MYO6 Gene Deafness Autosomal Dominant Type 22 NGS Genetic DNA Test for $500 in USA. Advanced NGS technology detects hereditary hearing loss mutations. Available in New York
Get comprehensive COL4A3 Gene Alport Syndrome Autosomal Recessive NGS Genetic DNA Test for $500 in USA. Advanced NGS technology detects inherited kidney disease risk. Available in New York COL4A3 Gene Alport Syndrome Autosomal Recessive Genetic Test Original price was: $700.Current price is: $500.
Comprehensive CEACAM16 Gene Deafness Autosomal Dominant Type 4B NGS Genetic DNA Test available for $500 USD across USA. Advanced NGS technology detects hereditary hearing loss mutations. Get accurate diagnosis for genetic deafness with results in 3-4 weeks. Book your test today in major cities including New York CEACAM16 Gene Deafness Autosomal Dominant Type 4B Genetic Test Original price was: $700.Current price is: $500.
Sale!

MYO6 Gene Deafness Autosomal Dominant Type 22 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MYO6 Gene Deafness Autosomal Dominant Type 22 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the MYO6 gene responsible for hereditary hearing loss. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variations associated with autosomal dominant nonsyndromic hearing loss. Individuals experiencing progressive hearing impairment, those with family history of genetic deafness, or patients seeking genetic counseling for hearing disorders should consider this test. The analysis provides crucial information for early intervention, personalized treatment planning, and family genetic counseling. Results typically available within 3-4 weeks from blood or DNA samples. This essential diagnostic tool costs $500 USD and offers significant benefits for managing hereditary hearing conditions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MYO6 Gene Deafness Autosomal Dominant Type 22 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Hereditary Hearing Loss

The MYO6 Gene Deafness Autosomal Dominant Type 22 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for hereditary hearing disorders. This advanced testing methodology provides crucial insights into the genetic basis of nonsyndromic hearing loss, enabling early detection and personalized management strategies for affected individuals and families.

What This Test Measures and Detects

This sophisticated genetic analysis specifically targets mutations in the MYO6 gene, which encodes myosin VI – a critical motor protein essential for proper inner ear function and auditory signal transmission. The test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the entire MYO6 gene sequence, identifying:

  • Point mutations and single nucleotide variants
  • Insertions and deletions affecting gene function
  • Missense and nonsense mutations impacting protein structure
  • Regulatory region variations affecting gene expression
  • Novel genetic variants associated with hearing impairment

Who Should Consider This Genetic Test

This comprehensive genetic analysis is particularly recommended for individuals experiencing:

  • Progressive sensorineural hearing loss beginning in childhood or early adulthood
  • Family history of autosomal dominant hearing impairment
  • Unexplained bilateral hearing loss without environmental causes
  • Patients undergoing genetic counseling for hereditary hearing disorders
  • Individuals with suspected genetic predisposition to hearing impairment
  • Family members of individuals diagnosed with MYO6-related hearing loss

Significant Benefits of Genetic Testing

Undergoing the MYO6 Gene Deafness Autosomal Dominant Type 22 NGS Genetic DNA Test offers numerous advantages:

  • Early Detection and Intervention: Identify genetic predisposition before significant hearing loss occurs
  • Personalized Treatment Planning: Develop targeted management strategies based on genetic findings
  • Family Genetic Counseling: Provide accurate risk assessment for family members
  • Reproductive Planning: Make informed decisions about family planning and genetic inheritance
  • Comprehensive Diagnosis: Obtain definitive answers about the genetic basis of hearing impairment
  • Research Contribution: Contribute to ongoing scientific understanding of genetic hearing disorders

Understanding Your Test Results

Your genetic test results will provide detailed information about MYO6 gene variations and their clinical significance:

  • Positive Result: Indicates the presence of pathogenic MYO6 mutations associated with hearing loss, requiring follow-up with ENT specialists and genetic counselors
  • Negative Result: Suggests no detectable MYO6 mutations, though other genetic or environmental factors may contribute to hearing issues
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing monitoring and potential family studies
  • Carrier Status: Determines inheritance patterns and family transmission risks

Test Pricing Information

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Schedule Your Genetic Test Today

Take the first step toward understanding your genetic hearing health. Our experienced genetic counselors and ENT specialists are ready to guide you through the testing process and help interpret your results. Contact us today to schedule your appointment and begin your journey toward comprehensive genetic understanding.

Call or WhatsApp: +1(267) 388-9828 to book your MYO6 Gene Deafness Autosomal Dominant Type 22 NGS Genetic DNA Test and receive professional genetic counseling services.

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Testing Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: ENT Doctor
  • Department: Genetics
  • Disease Category: Ear Nose Throat Disorders

Our commitment to excellence in genetic testing ensures you receive the most accurate, reliable results to inform your healthcare decisions and improve your quality of life.

SKU: 4063 Category:

Related products